Dr. Tang Weikun, aged 36, joined Grand Pharma (China) Co., Ltd. (a major subsidiary of the Group) (“Grand Pharma (China)”) in 2012 and worked for several companies of the Group. He has been the assistant of the president of Grand Pharma (China) since April 2019 and was appointed as the president of Grand Pharma (China) with effect from 1 June 2021. Dr. Tang has overall responsibility for the operation of Grand Pharma (China). Dr. Tang completed his life science and technology undergraduate education at Wuhan University in 2007 and obtained his doctoral degree in microbiology from the College of Life Sciences, Wuhan University in 2012.